V

Vesalius Therapeutics

AI-driven drug target discovery platform

Director Corporate Strategy

Corporate StrategyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • At least 8 years of relevant experience in biotechnology or pharmaceutical business development, investor relations, corporate strategy, management consulting, investment banking, or a comparable role.
  • Demonstrated experience in at least two of business development, investor relations, and corporate or portfolio strategy, with the ability to contribute across all three.
  • Strong understanding of biotechnology research and development, clinical development, portfolio strategy, partnering, and drivers of enterprise value.
  • Experience evaluating partnerships or licensing opportunities, including diligence, valuation, financial modeling, and transaction support.
  • Ability to translate complex scientific and clinical information into clear materials for investors, partners, executives, and the Board.
  • Ability to lead cross-functional work, manage multiple high-priority workstreams, and build external relationships without formal authority.
  • Bachelor's degree required.

Responsibilities

  • Support development and ongoing refinement of the enterprise strategy, strategic priorities, portfolio plan, and long-range plan.
  • Lead portfolio and scenario analyses integrating scientific differentiation, clinical path, probability of success, investment requirements, competitive context, and potential value.
  • Create decision frameworks for program prioritization, resource allocation, sequencing, partnering, financing, and organizational investment.
  • Facilitate cross-functional strategy discussions and translate conclusions into accountable plans, milestones, and decision follow-up.
  • Lead market, competitive, pipeline, modality, company, and financing-environment analyses to inform corporate and program strategy.
  • Synthesize scientific, clinical, regulatory, commercial, and financial information into concise implications and recommendations for senior leadership and the Board.
  • Develop scenario analyses, valuations, and financial models to evaluate strategic alternatives, investment needs, milestones, and value-creation pathways.
  • Develop executive and Board materials, and partner with Finance and functional leaders on annual planning, resource allocation, operating priorities, and milestone tracking.
  • Develop and maintain a business development strategy aligned with enterprise and portfolio priorities.
  • Identify, assess, and prioritize licensing, collaboration, partnership, and other external growth opportunities.
  • Lead or coordinate partner outreach, scientific and business presentations, cross-functional diligence, and integrated recommendations on strategic fit, value, risk, and execution requirements.
  • Develop valuations and transaction scenarios, support deal structuring and negotiations with leadership, Finance, and Legal, and help transition completed transactions into effective alliance governance.
  • Help shape the investor engagement strategy, engagement plan, and financing narrative in partnership with the executive team and Finance.
  • Develop and maintain investor presentations, corporate messaging, Q&A, diligence materials, and other communications that connect scientific and clinical progress to enterprise value.
  • Prepare executives for investor meetings, conferences, financing discussions, and follow-up; coordinate accurate, consistent inputs across scientific, clinical, financial, and legal stakeholders.
  • Monitor investor feedback, peer-company positioning, market sentiment, and the financing environment, and translate external insights into recommendations for leadership.

Desired Qualifications

  • An advanced degree in business, science, medicine, engineering, or a related field.
  • Experience working across strategy, business development, or investor relations in an early-stage or clinical-stage biotechnology company.
  • Experience in CNS, neurodegeneration, Alzheimer's disease, or complex disease areas.
  • Direct experience supporting licensing transactions, strategic partnerships, private financings, investor meetings, or related external processes.
  • Experience developing investor narratives and materials for a venture-backed or publicly traded biotechnology company.
  • Familiarity with human genetics, data-driven drug discovery, and platform-based biotechnology models.
  • Experience supporting executive teams and Boards through major portfolio, financing, or partnering decisions.

About the Company

Vesalius Therapeutics

AI-driven drug target discovery platform

Vesalius Therapeutics develops drugs for common diseases using its ContinuumDiscovery platform. The platform combines data science, artificial intelligence, and machine learning to identify distinct patient subgroups and the combined effects of multiple genes, then finds optimal drug targets to reverse disease in those groups. It also uses proprietary patient-derived, cell-based models to screen and characterize drug candidates. Unlike traditional approaches that treat common diseases as single conditions, Vesaliusus views them as a collection of genetically and biologically different subtypes, and it targets these unique characteristics with tailored drug development. The company aims to develop and commercialize novel therapies that address these genetic and biological differences to improve patient outcomes.

Company size
11-50
Company stage
Series A
Total funding
$75M
Headquarters
Cambridge, MA
Founded
2019

Recently Posted Jobs

Explore more opportunities at Vesalius Therapeutics

See more jobs